MedPath

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Phase 3
Active, not recruiting
Conditions
Progressive Familial Intrahepatic Cholestasis
Interventions
Drug: A4250 (odevixibat)
Registration Number
NCT03659916
Lead Sponsor
Albireo, an Ipsen Company
Brief Summary

Open Label Extension Study to evaluate long term safety and persistence of effect of A4250 in children with PFIC.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
116
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
A4250A4250 (odevixibat)Capsules for oral administration (40 or 120 ยตg/kg) once daily for 72 weeks, or 40 ยตg/kg/day for the first 12 weeks followed by 120 ยตg/kg/day for the remaining 60 weeks"
Primary Outcome Measures
NameTimeMethod
US: Change in PruritusFrom baseline over 72 weeks

Change in pruritus as indexed by caregiver-reported (Albireo ObsRO instrument) observed scratching

EU and rest of world: Change in serum bile acidsFrom baseline up to week 72
Secondary Outcome Measures
NameTimeMethod
All regions. All-cause mortalityFrom baseline to weeks 24, 48, and 72
EU and rest of world: Proportion of positive pruritus assessments at the patient level over the 72-week treatment period using the Albireo ObsRO instrument.72 weeks
US: Change from baseline in serum bile acids after 72 weeks of treatment.72 weeks
All regions: Proportion of individual assessments meeting the definition of a positive pruritus assessment at the patient level using the Albireo ObsRO instrument.weeks 0-4, 0-12, 0-22, 0-24, 0-36, 0-46, 0-48, 0-60, 0-70, or the proportion of positive pruritus assessments at each 4-week interval between V1/Screening and V5/Week 24, then by each visit between V5/Week 24 to V12/Week 76
All regions: Proportion of individual PM assessments meeting the definition of a positive pruritus assessment at the patient level using the Albireo ObsRO instrumentweeks 0-4, 0-12, 0-22, 0-24, 0-36, 0-46, 0-48, 0-60, 0-70, or the proportion of positive pruritus assessments at each 4-week interval between V1/Screening and V5/Week 24, then by each visit between V5/Week 24 to V12/Week 76
All regions: Number of patients undergoing biliary diversion surgeryFrom baseline to weeks 24, 48, and 72
All regions: Number of patients undergoing liver transplantationFrom baseline to weeks 24, 48, and 72
All regions: Change in growthFrom baseline to weeks 24, 48, and 72

The linear growth deficit compared to the standard growth curve

All regions: Change in AST to platelet ratio idex (APRI) scoreFrom baseline to week 72
All regions: 3. Change from baseline in serum bile acids at Weeks 4, 12, 22, 24, 36, 46, 48, 60, 70, 72, and 76Weeks 4, 12, 22, 24, 36, 46, 48, 60, 70, 72, and 76
All regions: Proportion of individual AM assessments meeting the definition of a positive pruritus assessment at the patient level using the Albireo ObsRO instrumentweeks 0-4, 0-12, 0-22, 0-24, 0-36, 0-46, 0-48, 0-60, 0-70, or the proportion of positive pruritus assessments at each 4-week interval between V1/Screening and V5/Week 24, then by each visit between V5/Week 24 to V12/Week 76
All regions: Change in Fib-4 scoreFrom baseline to week 72
All regions: Change in pediatric end-stage liver disease (PELD)/model for end-stage liver disease (MELD) scoreFrom baseline to week 72
All regions: Change in use of antipruritic medicationFrom baseline to weeks 24, 48, and 72

Trial Locations

Locations (41)

Children's Hospital Los Angeles

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Emory University School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

Johns Hopkins School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Children's Hospital of Philadelphia

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Children's Hospital of Pittsburgh

๐Ÿ‡บ๐Ÿ‡ธ

Pittsburgh, Pennsylvania, United States

Akdeniz University

๐Ÿ‡น๐Ÿ‡ท

Antalya, Turkey

Riley Hospital for Children - Riley Children's Specialists

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Icahn School of Medicine at Mount Sinai

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Columbia University Medical Center - Presbyterian Hospital Building

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Cliniques Universitaires Saint-Luc

๐Ÿ‡ง๐Ÿ‡ช

Woluwe-Saint-Lambert, Belgium

Baylor College of Medicine - Texas Children's Liver Center

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

The Royal Children's Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne, Australia

University and Pediatric Hospital of Lyon

๐Ÿ‡ซ๐Ÿ‡ท

Bron, France

Universite Paris SUD - Hpitaux Universitaires Paris-Sud - Hopital Bicetre

๐Ÿ‡ซ๐Ÿ‡ท

Le Kremlin-Bicรชtre, France

Hospital De La Timone

๐Ÿ‡ซ๐Ÿ‡ท

Marseille, France

Hospital Necker-Enfants Maladies

๐Ÿ‡ซ๐Ÿ‡ท

Paris, France

Medizinische Hochschule Hannover

๐Ÿ‡ฉ๐Ÿ‡ช

Hannover, Germany

Kinderklinik Tubingen, Universitatsklinikum Tubingen

๐Ÿ‡ฉ๐Ÿ‡ช

Tรผbingen, Germany

Univesitatsklinikum Tubingen Klinik fur Kinder und Jugendmedizin

๐Ÿ‡ฉ๐Ÿ‡ช

Tรผbingen, Germany

University Medical Center Groningen

๐Ÿ‡ณ๐Ÿ‡ฑ

Groningen, Netherlands

King Faisal Specialist Hospital & Research Centre

๐Ÿ‡ธ๐Ÿ‡ฆ

Riyadh, Saudi Arabia

Hospital Universitari Vall d'Hebron

๐Ÿ‡ช๐Ÿ‡ธ

Barcelona, Spain

Instytut Pomnik - Centrum Zarowia Dziecka

๐Ÿ‡ต๐Ÿ‡ฑ

Warsaw, Poland

Hospital Universitario La Paz

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

Astrid Lindgren Children's Hospital, Karolinska University Hospital

๐Ÿ‡ธ๐Ÿ‡ช

Solna, Sweden

Gazi University

๐Ÿ‡น๐Ÿ‡ท

Ankara, Turkey

Hacettepe University Faculty of Medicine

๐Ÿ‡น๐Ÿ‡ท

Ankara, Turkey

Istanbul University Medical Faculty

๐Ÿ‡น๐Ÿ‡ท

Istanbul, Turkey

Inonu University Medical Faculty

๐Ÿ‡น๐Ÿ‡ท

Malatya, Turkey

Leeds General Infirmary

๐Ÿ‡ฌ๐Ÿ‡ง

Leeds, United Kingdom

Birmingham Women's and Children's NHS Foundation Trust

๐Ÿ‡ฌ๐Ÿ‡ง

Birmingham, United Kingdom

Institute of Liver Studies - Kings College Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Universitair Medisch Centrum (UMC) Utrecht

๐Ÿ‡ณ๐Ÿ‡ฑ

Utrecht, Netherlands

Schneider Children's Medical Center Of Israel

๐Ÿ‡ฎ๐Ÿ‡ฑ

Petach-Tikva, Israel

Shaare-Zedek Mc

๐Ÿ‡ฎ๐Ÿ‡ฑ

Jerusalem, Israel

Azienda Ospedaliera Papa Giovanni XXIII

๐Ÿ‡ฎ๐Ÿ‡น

Bergamo, Italy

University Hospital Of Padova

๐Ÿ‡ฎ๐Ÿ‡น

Padova, Italy

Ospedale Regina Margherita

๐Ÿ‡ฎ๐Ÿ‡น

Torino, Italy

Children's Hospital Colorado

๐Ÿ‡บ๐Ÿ‡ธ

Denver, Colorado, United States

The Hospital for Sick Children

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Canada

Washington University School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Saint Louis, Missouri, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath